Assignee
NEUROCYCLE THERAPEUTICS INC
US·3 granted patents·3 pending applications·3 citations·filing 2020–2024
Top patents by PatentIndex Score
6 records- 0186US12134619B2Crystalline salts or co-crystals of 2′,6-difluoro-5′-[3-(1-hydroxy-1-methylethyl)-imidazo[1,2-b][1,2,4]triazin-7-yl]biphenyl-2-carbonitrile with p-toluenesulofonic acid as GABAA positive allosteric modulatorsNEUROCYCLE THERAPEUTICS INC·Filed 2022·Granted Nov 5, 2024·2 cites·21 claims
- 0278US11542263B2Crystalline salts or co-crystals of 2′,6-difluoro-5′-[3-(1-hydroxy-1-methylethyl)-imidazo[1,2-b] [1,2,4]triazin-7-yl]biphenyl-2-carbonitrile with phosphoric acid as GABAA positive allosteric modulatorsNEUROCYCLE THERAPEUTICS INC·Filed 2020·Granted Jan 3, 2023·1 cites·23 claims
- 0372US2025034155A1CRYSTALLINE SALTS OR CO-CRYSTALS OF 2',6-DIFLUORO-5'-[3-(1-HYDROXY-1-METHYLETHYL)-IMIDAZO[1,2-b][1,2,4]TRIAZIN-7-YL]BIPHENYL-2-CARBONITRILE WITH PHOSPHORIC ACID AS GABAA POSITIVE ALLOSTERIC MODULATORSNEUROCYCLE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0454US11571421B2GABAA positive allosteric modulator compounds for treatment of itch and/or dermatitisNEUROCYCLE THERAPEUTICS INC·Filed 2020·Granted Feb 7, 2023·0 cites·26 claims
- 0546US2023020036A1Treatment of epileptic conditions with gabaa receptor modulatorsNEUROCYCLE THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 0642US2023017378A1Gabaa positive allosteric modulator compounds, methods of making, and uses thereofNEUROCYCLE THERAPEUTICS INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when NEUROCYCLE THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →